Lanean...
Harnessing the PD-1 Pathway in Renal Cell Carcinoma: Current Evidence and Future Directions
Programmed cell death-1 (PD-1) is a recognized immune checkpoint. It is frequently upregulated on the T cells that infiltrate tumors, providing an inhibitory signal, which may facilitate immune escape. Blocking antibodies have been developed to interrupt the interaction of PD-1 with its ligands PD-L...
Gorde:
| Argitaratua izan da: | BioDrugs |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888066/ https://ncbi.nlm.nih.gov/pubmed/25445176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-014-0111-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|